{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:23:03Z","timestamp":1770978183710,"version":"3.50.1"},"reference-count":18,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,2,22]]},"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>A 14-year-old boy was referred to the ophthalmology department with a 4-day history of rapid-onset right upper lid pain, swelling and erythema starting 9\u2009hours after his first dose of COVID-19 mRNA vaccination (BNT162b2\/Comirnaty, Pfizer-BioNTech). On examination, he had significant right upper lid ptosis, oedema and erythema, with associated limitation of right eye abduction and elevation. He was found to have acute dacryoadenitis with orbital inflammatory disease on clinical and laboratory investigations. He was given tapering oral prednisone and had full resolution of symptoms within 2\u2009weeks. This is the first known case of orbital inflammation after COVID-19 mRNA vaccination. Given the temporal association between the patient\u2019s vaccination and symptom onset, we believe it is likely that immunisation prompted the onset of disease.<\/jats:p>","DOI":"10.1136\/bcr-2021-248441","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T10:50:39Z","timestamp":1646650239000},"page":"e248441","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Acute-onset dacryoadenitis following immunisation with mRNA COVID-19 vaccine"],"prefix":"10.1136","volume":"15","author":[{"given":"Treasa","family":"Murphy","sequence":"first","affiliation":[{"name":"Ophthalmology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Raheem Abu Shanab","sequence":"additional","affiliation":[{"name":"Ophthalmology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristopher","family":"Kang","sequence":"additional","affiliation":[{"name":"Paediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J","family":"Lyons","sequence":"additional","affiliation":[{"name":"Ophthalmology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada"},{"name":"Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"2025082800540529000_15.3.e248441.1","first-page":"138","article-title":"Unique characteristics of lacrimal glands as a part of mucosal immune network: high frequency of IgA-committed B-1 cells and NK1.1+ alphabeta T cells","volume":"41","author":"Saitoh-Inagawa","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025082800540529000_15.3.e248441.2","first-page":"1","article-title":"Acute dacryoadenitis in a patient with SARS-CoV-2 infection","author":"Mart\u00ednez D\u00edaz","year":"2021","journal-title":"Orbit"},{"key":"2025082800540529000_15.3.e248441.3","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.2147\/OPTH.S269868","article-title":"The role of the ocular tissue in SARS-CoV-2 transmission","volume":"14","author":"Peng","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"2025082800540529000_15.3.e248441.4","doi-asserted-by":"crossref","first-page":"100917","DOI":"10.1016\/j.ajoc.2020.100917","article-title":"Episcleritis as a possible presenting sign of the novel coronavirus disease: a case report","volume":"20","author":"Otaif","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2025082800540529000_15.3.e248441.5","first-page":"513","article-title":"Anterior acute uveitis report in a SARS-CoV-2 patient managed with adjunctive topical antiseptic prophylaxis preventing 2019-nCoV spread through the ocular surface route","volume":"13","author":"Mazzotta","year":"2020","journal-title":"Int Med Case Rep J"},{"key":"2025082800540529000_15.3.e248441.6","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31014-X","article-title":"Retinal findings in patients with COVID-19","volume":"395","author":"Marinho","year":"2020","journal-title":"Lancet"},{"key":"2025082800540529000_15.3.e248441.7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/01676830.2020.1768560","article-title":"Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19","volume":"39","author":"Turbin","year":"2020","journal-title":"Orbit"},{"key":"2025082800540529000_15.3.e248441.8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaapos.2021.04.002","article-title":"Orbital inflammatory disease associated with COVID-19 infection","volume":"25","author":"Eleiwa","year":"2021","journal-title":"J Aapos"},{"key":"2025082800540529000_15.3.e248441.9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/APO.0000000000000453","article-title":"COVID-19: update on its ocular involvements, and complications from its treatments and vaccinations","volume":"10","author":"Lin","year":"2021","journal-title":"Asia Pac J Ophthalmol"},{"key":"2025082800540529000_15.3.e248441.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00076-1"},{"key":"2025082800540529000_15.3.e248441.11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamaoto.2021.1259","article-title":"Association of COVID-19 vaccination and facial nerve palsy: a case-control study","volume":"147","author":"Shemer","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2025082800540529000_15.3.e248441.12","doi-asserted-by":"crossref","DOI":"10.1186\/s12348-021-00275-x","article-title":"Ocular inflammatory events following COVID-19 vaccination: a multinational case series","volume":"12","author":"Testi","year":"2022","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2025082800540529000_15.3.e248441.13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/09273948.2021.1962917","article-title":"Acute uveitis following COVID-19 vaccination","volume":"29","author":"ElSheikh","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"2025082800540529000_15.3.e248441.14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40123-021-00415-5","article-title":"The eye of the storm: COVID-19 vaccination and the eye","volume":"11","author":"Ng","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"2025082800540529000_15.3.e248441.15","doi-asserted-by":"crossref","first-page":"101136","DOI":"10.1016\/j.ajoc.2021.101136","article-title":"Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine","volume":"23","author":"Fowler","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2025082800540529000_15.3.e248441.16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41433-021-01610-1","article-title":"Acute macular neuroretinopathy following COVID-19 vaccination","volume":"36","author":"B\u00f8hler","year":"2022","journal-title":"Eye"},{"key":"2025082800540529000_15.3.e248441.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24285-4"},{"key":"2025082800540529000_15.3.e248441.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000733","article-title":"SARS-CoV-2 RNA and antibodies in tear fluid","volume":"6","author":"Muyldermans","year":"2021","journal-title":"BMJ Open Ophthalmol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-248441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:54:14Z","timestamp":1756367654000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-248441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,7]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/bcr-2021-248441"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-248441","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}